Literature DB >> 21655679

Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE).

Pamela L Lutsey1, Mary Cushman, Susan R Heckbert, Weihong Tang, Aaron R Folsom.   

Abstract

Several studies have reported that taller individuals are at greater risk of venous thromboembolism (VTE). We hypothesised that longer leg length would be positively associated with incident VTE, and would explain the height association. LITE ascertained VTE in a prospective population-based sample of 21,860 individuals aged 45 and older. Leg length was measured as standing height minus torso length. Cox regression models were adjusted for age, race, sex, waist circumference, diabetes, and factor VIII. To evaluate whether leg length was associated with VTE risk independent of height, we standardised leg length and height per 1 standard deviation (SD), and then included them simultaneously in Cox regression models. A total of 641 incident VTE cases accrued over a median follow-up of 16 years. Participants in the highest quintile of leg length were at 59% (95% CI: 22%-108%) greater risk of VTE, relative to the lowest quintile. For height, risk was 45% (12%-88%) greater for those in the highest quintile, compared to the lowest. When leg length and height were modelled simultaneously leg length remained associated with VTE risk (HR per 1 SD: 1.21 (1.04-1.40) while height was unrelated (HR per 1 SD: 1.00 (0.86-1.16). To conclude, participants with longer legs were at greater risk of incident VTE, and leg length explained the relation of height to VTE. It remains to be established whether this finding is due to greater venous surface area, a larger number of venous valves, or greater hydrostatic pressure among individuals with longer legs.

Entities:  

Mesh:

Year:  2011        PMID: 21655679      PMCID: PMC3180885          DOI: 10.1160/TH11-02-0100

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

1.  Can adult anthropometry be used as a 'biomarker' for prenatal and childhood exposures?

Authors:  David Gunnell
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

2.  The effect of aging on venous valves.

Authors:  Kirsten van Langevelde; Alexandr Srámek; Frits R Rosendaal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

3.  Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

Authors:  J A Heit; D N Mohr; M D Silverstein; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

4.  Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study.

Authors:  A Fronek; M H Criqui; J Denenberg; R D Langer
Journal:  J Vasc Surg       Date:  2001-05       Impact factor: 4.268

5.  Hypertension-induced venous valve remodeling.

Authors:  Shinya Takase; Luigi Pascarella; John J Bergan; Geert W Schmid-Schönbein
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

Review 6.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.

Authors:  Mary Cushman; Albert W Tsai; Richard H White; Susan R Heckbert; Wayne D Rosamond; Paul Enright; Aaron R Folsom
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

9.  ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.

Authors:  A C Papp; H Hatzakis; A Bracey; K K Wu
Journal:  Thromb Haemost       Date:  1989-02-28       Impact factor: 5.249

10.  Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort.

Authors:  M E J Wadsworth; R J Hardy; A A Paul; S F Marshall; T J Cole
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

View more
  11 in total

Review 1.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

2.  Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.

Authors:  N S Roetker; S M Armasu; J S Pankow; P L Lutsey; W Tang; M A Rosenberg; T M Palmer; R F MacLehose; S R Heckbert; M Cushman; M de Andrade; A R Folsom
Journal:  J Thromb Haemost       Date:  2017-06-06       Impact factor: 5.824

3.  Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Mary Cushman; Ellen S O'Meara; Susan R Heckbert; Neil A Zakai; Wayne Rosamond; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-06-15       Impact factor: 3.944

4.  Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study.

Authors:  Morten Schmidt; Hans Erik Bøtker; Lars Pedersen; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2013-12-14       Impact factor: 8.082

5.  Association between greater leg length and increased incidence of colorectal cancer: the atherosclerosis risk in communities (ARIC) study.

Authors:  Guillaume Onyeaghala; Pamela L Lutsey; Ellen W Demerath; Aaron R Folsom; Corinne E Joshu; Elizabeth A Platz; Anna E Prizment
Journal:  Cancer Causes Control       Date:  2019-06-04       Impact factor: 2.506

6.  Taller women are at greater risk of recurrent venous thromboembolism: the Iowa Women's Health Study.

Authors:  Pamela L Lutsey; Aaron R Folsom
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

Review 7.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

8.  Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.

Authors:  Elizabeth J Bell; Sunil K Agarwal; Mary Cushman; Susan R Heckbert; Pamela L Lutsey; Aaron R Folsom
Journal:  Am J Hypertens       Date:  2015-08-25       Impact factor: 2.689

Review 9.  Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

Authors:  Scott M Stevens; Scott C Woller; Kenneth A Bauer; Raj Kasthuri; Mary Cushman; Michael Streiff; Wendy Lim; James D Douketis
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients.

Authors:  Kristina Kupcinskiene; Martyna Murnikovaite; Greta Varkalaite; Simonas Juzenas; Darius Trepenaitis; Ruta Petereit; Almantas Maleckas; Juozas Kupcinskas; Andrius Macas
Journal:  Dis Markers       Date:  2016-11-23       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.